Reduce the time and cost for managing claims processing and underwriting with Computer Vision and NLP.
Computer vision and AI help to simplify and streamline the property assessment, risk analysis and post damage assessment process. Using Clarifai’s image recognition, reduce the time and cost for assessing and underwriting claims. Ultimately improving the collaboration between agents and customers for a better customer experience.
Our Pharma solution analyzes Real World Evidence (RWE) repetitively to find the drug risks.
Real World Data (RWD) source includes wide variety of patient data from Electronic Health Record(EHR), claims, billing and health data collected from IOT and hand held devices.
Improve Trial prospects be more robust with diverse population and less bias.
Individual Case Safety Report (ICSR) Prevent Duplicate Reporting Permit follow-up for additional info Allow Anonymous Report Drug with various trade names across world.
AI platform streamlines pharma processes, saves time, reduces errors in drug discovery, clinical trials, compliance.
AI platform extracts info from unstructured data using vision, NLP, OCR, improving quality and analysis.
AI platform provides pharma with timely, accurate insights to identify safety risks, predict trends, and optimize supply chain.
AI platform speeds up drug discovery, enables better patient insights, and accelerates time-to-market for innovative treatments.
AI platform automates compliance tasks, monitors in real-time, ensures pharma regulatory compliance (e.g., FDA electronic submission), reduces risk.
AI platform cuts pharma costs, streamlines processes, reduces errors, boosts profitability.
The pharma industry must ensure drug safety and quality throughout the drug lifecycle. Pharmacovigilance involves collecting, analyzing, and communicating adverse effects of drugs. AI can help automate tasks, improve accuracy, and enhance decision-making.
Pharmacovigilance, the process of monitoring the safety of drugs, can be improved by employing AI in post-market monitoring to simplify signal detection, aggregate reporting, causality assessment, and confirmation/refutation of adverse events, reducing compliance costs and improving the accuracy of adverse event reporting.
We can help you advance your AI projects. Contact us to schedule a demo to learn about our AI-driven solutions.